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Acute transforming retroviruses have arisen in nature by recombination of repli- 
cation-competent type C viruses with cellular genes. By a number of approaches, the 
cell-derived information of these viruses has been shown to be intimately involved in 
their transforming functions (for reviews see refs. 1, 2). A limited number of such cell- 
derived  onc  genes  have  been  incorporated  into  retroviral  genomes.  In  some  cases, 
different retrovirus isolates have incorporated closely related onc genes from the same, 
or even different species (3-12). One such group of related sarcoma-inducing viruses 
includes the mouse-derived BALB-murine sarcoma virus (MSV)1 (13), and rat-derived 
Harvey-MSV  (14).  Analysis  of the  molecularly cloned  BALB-MSV  genome  has 
revealed that its oncgene,  designated bas, is closely related to the rat-derived onc gene, 
ras, of Harvey-MSV (8). 
BALB- and Harvey-MSV, like most transforming retroviruses, induce solid tumors 
in vivo. In tissue culture, study of such viruses has been generally limited to analysis 
of their transforming effects on fibroblast cell lines.  Recent studies  have indicated 
that Harvey-MSV, in addition to its ability to cause sarcomas, can induce proliferation 
of hematopoietic cells of the erythroid series both in vivo (15)  and in tissue culture 
(16). 
Investigation  of the  diversity of target  cells  for neoplastic  transformation  by  a 
particular transforming retrovirus might be expected to provide insights into pathways 
of transformation, and in particular, the relationship of the differentiated state of the 
cell to its susceptibility to onc gene action. In the present report, we demonstrate the 
transforming action of BALB- and Harvey-MSV for a  unique hematopoietic target 
cell both in tissue culture and in vivo. 
Materials and Methods 
Cells  and  Viruses.  Cell  lines  included  NIH/3T3  (17),  a  clonal  BALB-MSV nonproducer 
transformant of NIH/3T3 cells (8), an Abelson-murine  leukemia  virus  (MuLV) transformed 
nonproducer clone of NIH/3T3 cells (ANN-1) (18), and a Harvey-MSV transformed nonpro- 
ducer clone of NRK (S.A. Aaronson, unpublished observations). Mouse type C helper leukemia 
viruses included clonal strains of Rauscher-MuLV (19), and amphotrophic (Amph)-MuLV (20, 
21). MuLV pseudotypes of BALB-MSV, Abelson-MuLV,  and Harvey-MSV were obtained by 
1Abbreviations used in  this paper: Amph,  amphotropic  virus;  DMSO,  dimethyl  sulfoxide;  FFU,  focus- 
forming unit; ME, mercaptoethanol; MSV, murine sarcoma virus;  MuLV, murine leukemia virus;  PBS, 
phosphate-buffered  saline;  REV-T,  reticuloendotheliosis  virus;  SRBC,  sheep  erythrocytes;  Staph  A, 
staphylococcus  A; TdT, terminal deoxynucleotidyl transferase. 
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superinfection of appropriate nonproducer cells (22,  23). The titer of the defective transforming 
viruses, expressed as focus-forming units/ml  (FFU/ml), were determined on NIH/3T3 cells as 
previously described (22). 
Murine hematopoietic cell lines included a clonal Rauscher-MuLV transformed NIH/Swiss 
pre-B cell line, 6EC4, that has been shown to synthesize ~ chain (24), a  clonal Thy-1  antigen- 
positive Moloney-MuLV transformed NIH/Swiss T  cell line, 19-I-2 (24), and a Friend-MuLV 
transformed  erythroblast  line,  clone  745,  that  is  dimethyl  sulfoxide  (DMSO)  inducible  for 
hemoglobin synthesis (25). 
Hematopoietic Colony Formation Assay.  Bone  marrow  suspensions  were  prepared  from  the 
femurs  and  tibias  of  2-3-wk-old  NFS/N  mice.  Single-cell  suspensions  were  washed  and 
resuspended at a  density of 2 ×  106 nucleated cells/ml in RPMI  1640 medium  (Grand Island 
Biological Co., Grand  Island,  NY)  containing 20%  heat-inactivated  fetal calf serum  (Reheis 
Chemical Co., Phoenix, AZ), and 5 ×  10  -5 M  mercaptoethanol  (Sigma Chemical Co., St. Louis, 
MO). 
Single-cell suspensions of NFS/N bone marrow were exposed to virus for 1 h at 37°C in the 
presence of 4 tLg/ml polybrene (Aldrich Chemical Co., Milwaukee, WI). After centrifugation, 
the cells were mixed with semisolid agarose medium containing RPMI  1640 medium supple- 
mented with 20% fetal calf serum, 5 ×  10 .5 M  mercaptoethanol  (ME), and 0.47% Sea Plaque 
agarose  (FMC Corp., Homer City, PA)  and plated at the appropriate  concentration into 35- 
mm petri dishes in a  volume of 2 ml. Plates were cooled at 4°C to allow solidification of the 
agarose, and the cultures were incubated  at 37°C in a  5% CO2 humidified incubator.  1 ml of 
agarose  medium was overlaid at  5-d intervals.  Visible colonies were scored at  12-18  d  after 
infection. 
Establishment of BALB-MSV- and Harvey-MSV-Transformed Hematopoietic Cell Lines.  Individual 
colonies were removed from the agarose plates and suspended in 1 ml of RPMI growth medium 
in 24-well microtiter plates (Costar, Data Packaging, Cambridge, MA). When the cell number 
in an individual well reached ~ 106 cells, the cells were transferred at a  1:2 split ratio. After an 
initial adaptation  period of 1-6 wks, the suspension lines could be maintained by transferring 
at  2-3-d  intervals  (split  ratio  of  1:20-1:100).  In  some cases,  bone  marrow  cell-conditioned 
medium  or secondary  adherent  bone  marrow  cell feeder layers were  used  during  an  initial 
adaptation period needed to establish hematopoietic cell lines. Any clones that were exposed to 
normal bone marrow feeder layers were recloned in soft agar before further characterization. 
For preparation of feeder layers or conditioned medium, NFS/N bone marrow cell suspen- 
6  sions (10  nucleated cells/ml) were plated in 60-mm tissue culture plates in RPMI 1640 medium 
supplemented  with 20% horse serum  (Flow Laboratories,  Rockville, MD)  and  5  ×  10 -5 ME. 
Nonadherent cells and medium were removed after 5 d, and medium containing 15% fetal calf 
serum was used thereafter.  Conditioned medium was collected at  5-d intervals starting  10 d 
after initial cell plating. Secondary adherent bone marrow cultures were generated from  15-d- 
old primary cultures. Cells were trypsinized and plated at a final concentration of 2 X  105 cells/ 
ml in 60-mm tissue culture dishes. 
Analysis of Tumor Induction.  Clonal hematopoietic cell lines were washed twice in phosphate- 
buffered  saline  (PBS)  and  resuspended  at  a  final  concentration  of 2  ×  107  cells/ml,  For 
tumorigenicity testing, NFS/N weanlings were inoculated subcutaneously with 5 ×  105 cells in 
a  volume of 0.25 ml. Virus alone was inoculated subcutaneously in the same volume. 
Histochemical Staining. The  presence of a-napthyl  acetate  esterase was  determined  by cyto- 
chemical staining as described by Yam et al  (26)  using the Sigma research kit.  Hemoglobin- 
containing cells were detected by benzidine staining according to the method of Peterson and 
McConkey  (27).  In  some cases,  cells were  treated  with  1.5%  DMSO  (Fisher  Scientific Co., 
Pittsburgh,  PA) or 0.3 U  erythropoietin  (step 3)  (Connaught  Laboratories,  Ontario, Canada) 
for 4 d before staining. 
Nonspecific Phagocytosis.  The  ability  of cells  to  phagocytize  latex  beads  was  determined 
essentially  as  described  by  Raschke  et  al.  (28).  Cells  (2  ×  106/ml  growth  medium)  were 
incubated  for  1 h  with  109 latex beads/ml  (0.81  p.m Diam)  (Sigma Chemical Co.). Cells were 
washed three times with PBS, and a wet mount slide was observed under the light microscope 
at  400  ×  magnification for evidence of cellular uptake  of latex beads.  Cells with at  least  10 
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Lysozyme Analysis.  Lysozyme was assayed by the lysoplate assay as described by Osserman 
and Lawlor (29). Egg white lysozyme was used as a standard. Levels of lysozyme were expressed 
in ~g/106 cells. 
Detection of Thy-I Antigen. The presence of Thy-1 antigen was determined by an antibody- 
dependent cytotoxicity assay. The complement-mediated lysis assay was performed essentially 
as described by Reddy et al. (24). Briefly, 2 X  106 cells were incubated with a  1:25 dilution of 
monoclonal Thy-1 antigen (New England Nuclear, Boston, MA) for 1 h at room temperature. 
Cells were washed in PBS and incubated for  1 h  at 37°C with undiluted guinea pig serum 
(Grand Island Biological Co.) as the source of complement. Trypan blue (Flow Laboratories) 
diluted in PBS was added to the cells, and the percentage of lysed cells was determined by 
microscopic examination. 
Detection of Fc Receptors.  The presence of Fc receptors was determined by rosette formation 
essentially as described by Kerbel et al. (30). Briefly, 2 ×  106 sheep erythrocytes (SRBC) per ml 
were incubated in RPMI medium with an equal volume of a subagglutinating titer (1:1000)  of 
heat-inactivated sheep hemolysin for 30 min at 37°C with occasional shaking. A suspension of 
washed, sensitized SRBC (4 ×  10  v cells in 0.2 ml) was mixed with an equal volume containing 
4 X  105 test cells. Sodium azide was added at a  final concentration of 0.1%. The cell mixture 
was centrifuged at  100 g  for 5  rain, and  the pellet was gently resuspended.  Percent  rosette 
formation was determined by counting with a hemocytometer. Cells with at least three attached 
SRBC were scored as positive. 
Radioimmunoassayfor Immunoglobulin I~ Chain.  The amount of mouse immunogiobulin/~ chain 
present in cells was determined by competition radioimmunoassay as previously described (24). 
Terminal Deoxynucleotidyl Transferase (TdT) Assay.  The TdT enzymatic assay was performed 
according to the method of Barton et al. (31) with minor modifications. Briefly, 106 cells were 
washed three times in PBS, and the pellet was resuspended in  1 ml of potassium phosphate 
buffer at a final concentration of 0.25 M  (pH 7.5). Cell extracts were prepared by sonification 
and clarified at  100,000 g for 1 h. Terminal transferase activity in cell extracts was assayed in 
a reaction mixture containing 0.5 mM [3H]deoxyguanosine triphosphate (1,000 epm/pmol), 10 
mM oligo (dA)12-18 (P-L Biochemicals, Inc., Milwaukee, WI), 8 mM MgCle, 0.1% bovine serum 
albumin, 0.2 M  potassium cacodylate (pH  7.3),  and  1 mM 2-mereaptoethanol. The 0.25  ml 
reaction mixture, containing 1-10/~1 of cell extract, was incubated at 37°C for 1 h. Trichloracetic 
acid precipitates were collected on  millipore filters, washed,  and  dried, and  the amount  of 
radioactivity was  determined  by  liquid  scintillation. TdT  activity was  expressed  in  units 
equivalent to 1 nmol of dGTP incorporated per h. 
Biosynthetic Labeling and Immunoprecipitation.  The procedures for metabolic labeling with 35S- 
methionine and immunoprecipitation were as previously described (11). Briefly, 10  v transformed 
hematopoietic or normal thymus cells were labeled with 200/~Ci 35S-methionine (New England 
Nuclear, Boston, MA) for a 3-h period. The cells were disrupted in  1 ml of staphylococcus A 
(Staph A) lysing buffer, clarified, and 0.2-ml samples were incubated with 10/~1 goat anti-calf 
TdT serum (P-L Biochemicals, Inc.) or normal goat serum overnight at 4°C. Antigen-antibody 
complexes were precipitated with  protein A  sepharose CL-4B  (Pharmacia  Fine Chemicals, 
Piscataway,  NJ)  by  agitation  for  15  min  at  4°C,  washed  three  times  in  Staph  A  buffer, 
resuspended in sample buffer, and boiled for 2 min. Reduced samples were analyzed on sodium 
dodecyl sulfate-polyacrylamide gels.  Gels were then fixed, dried, and exposed to X-Omat R 
film (Eastman Kodak Co., Rochester, NY). 
Results 
BALB-MSV  Induces  Growth of Hematopoietic  Colonies  in Infected Bone  Marrow  Cultures. 
Several transforming retroviruses, including avian erythroblastosis (32),  myelocyto- 
matosis  (33),  myeloblastosis  (34),  and  retieuloendotheliosis viruses  (35),  as  well  as 
mammalian  Abelson  (36)  and  myeloproliferative viruses  (37)  preferentially cause 
hematopoietic  tumors.  In  some  cases,  tissue  culture  assays  for  transformation  of 
hematopoietic target  cells by such  viruses have  been  developed. To  investigate the 
effects of BALB-MSV on hematopoietic cells, we used a  colony-forming assay devel- 876  LYMPHOID PROGENITOR CELL TRANSFORMATION 
F1c.  1.  Morphology of BALB-MSV-induced colonies. (A)  Colony at  14  d  post-infection (bar 
equals 0.1 mm). (B) Wright-Giemsa-stained  preparations  of  cells from BALB-MSV-induced  colonies 
(bar equals 5 #m). 
oped  by Rosenberg and  Baltimore  (38)  for  detection  of hematopoietic  cells  trans- 
formed by Abelson  murine  leukemia virus  (MuLV).  Bone marrow cell suspensions 
obtained  from  2-3-wk-old  NFS/N  mice  were  infected  with  BALB-MSV  and  sus- 
pended in soft agar as described in Materials and Methods. By 7-10 d, large numbers 
of colonies were observed in BALB-MSV-infected but not in control cultures. 
The colonies appeared golden and iridescent under the microscope, were round or 
oblong in  shape,  and  possessed a  compact morphology (Fig.  1 A).  Cells within  the 
colonies  were  round  in  shape  and  nonadherent.  By  light  microscopy,  such  cells 
exhibited an undifferentiated blast cell morphology (Fig.  1 B). The majority of cells 
had  a  large eccentric  nucleus  with  a  scanty cytoplasmic rim  lacking any granules. 
Occasionally, cytoplasmic vacuoles were observed. There were no apparent morpho- 
logic differences in cells from 20 different colonies analyzed, although some variations 
in cell size were noted. 
The length of virus exposure required for optimal colony formation was found to 
be 1 h. Incubation for longer periods appeared to decrease cell viability and did not 
increase the  number of colonies detected.  Variation  in  the cell number plated  into 
soft agar from 5 ×  105 to 3 ×  106 cells correlated directly with the number of colonies 
formed (data not shown). As shown in Fig. 2, there was a linear relationship between 
the  number  of colonies  formed  and  the  amount  of virus  inoculated.  The  one-hit 
titration pattern suggested that colony formation was dependent on infection with a 
single virus particle. Colony formation was considerably less efficient than was focus 
formation in fibroblasts by the same BALB-MSV stock (Fig. 2).  This may be due to 
a limited number of susceptible target cells for infection and/or transformation within 
the bone marrow cell population. 
BALB-MSV, like other replication defective transforming retroviruses, can only be 
propagated in the presence of a type C helper virus. As shown in Table 1, helper virus 
alone  produced  no  detectable  colonies,  further  indicating  that  the  colony-forming JACALYN  HOELZER  PIERCE  AND  STUART  A.  AARONSON 
100 
~.•'J 10  ~ 
°  9 
IL 
0  1 
0.1 
877 
i  i  ! 
10 s  10 4  I0 s 
FFU/ML 
FIo.  2.  Dose-response  curve for  BALB-MSV induction of compact  bone marrow cell colonies. 
Bone marrow cells were infected with serial dilutions of BALB-MSV and suspended  at 2 ×  10  6 cells 
per plate in semi-solid agar medium as described  in Materials and Methods. Colonies were scored 
18 d after infection.  Each point represents  the mean result obtained from two plates. 
TABLE  I 
In  Vitro Hematopoietic Colony Formation Induced by BALB- and 
Harvey-MSV 
Virus source  Colonies/106  fibroblast 
FFU* 
Amph-MuLV  < 10  ° 
Rauscher-MuLV  < 10  ° 
BALB-MSV (Amph-MuLV)  2.5 X 10  a 
Harvey-MSV (Amph-MuLV)  1.1 ×  l0  a 
Harvey-MSV (Rauscher-MuLV)  4.5 ×  l02 
Abelson-MuLV (Amph-MuLV)  1.6 X 10  s 
* Bone marrow cell suspensions  from NFS/N weanlings  were infected with 
varying virus dilutions and plated at a concentration of 2 ×  106 nucleated 
cells into soft agar as described  in Materials and Methods. Hematopoietic 
colony formation was scored at  18 d. 
activity must be due to BALB-MSV.  We also investigated the ability of Harvey-MSV 
and  Abelson-MuLV  to induce hematopoietic  colonies.  Harvey-MSV  is a  rat-derived 
sarcoma  virus  (39,  40)  whose onc  gene  is  closely related  to  that  of BALB-MSV  (8). 
Like BALB-MSV,  Harvey-MSV  was found to induce the formation of hematopoietic 
colonies (Table I). Under  the same assay conditions, Abelson-MuLV  induced colonies 
with indistinguishable  morphology and  at a  comparable  efficiency. 
In  Vivo Infection  with BALB- and Harvey-MSV Leads to Induction  of Similar Hematopoietic 
Colonies. In view of our findings that BALB- and Harvey-MSV  induced hematopoietic 
cell colonies in tissue culture, we investigated whether such colonies could be detected 
in  virus  inoculated  animals.  Moribund  mice,  killed  2-3  weeks  after  infection  as 
newborns,  demonstrated  grossly  enlarged  spleens  containing  many  pale,  poorly  de- 
fined  foci. We also observed  gross  enlargement  of the  thymic  region,  which  has  not 878  LYMPHOID  PROGENITOR  CELL TRANSFORMATION 
TABLE II 
Colony Formation by Bone Marrow Cells  from BALB- and 
Harvey-MS  V-infected Mice 
Virus inoculated 
Colonies/10 e nucleated 
bone marrow ceils 
plated* 
BALB-MSV (Amph-MuLV) 
Harvey-MuSV (Amph-MuLV) 
Abelson-MuLV (Amph-MuLV) 
Amph-MuLV 
1.6 X  102 
3.9 ×  101 
9.6 ×  102 
<10  ° 
* Newborn NFS/N mice were inoculated intraperitoneally  with 5 ×  104 FFU 
of each transforming retrovirus. Bone marrow was removed from moribund 
mice at  2-3  wk,  and  single-cell suspensions were plated in  soft agar as 
decribed in Materials and Methods. Colony formation was scored at  12 d. 
The results represent mean values obtained from three individual animals in 
each group. Amph-MuLV-infected  mice, killed at 3 wk, demonstrated  no 
evidence of pathology. 
been previously reported. This pathology was not observed in helper virus-infected or 
-uninfected animals. When bone marrow cells from BALB- or Harvey-MSV infected 
animals were plated into soft agar, we observed the formation of compact colonies as 
early as 3-4 d  after plating. As shown  in Table II, the frequency of colony-forming 
cells ranged from 3.9 ×  101 to  1.6 ×  102 colonies per 106 nucleated bone marrow cells 
plated. The frequency of colony-forming cells in the bone marrow  cells of Abelson- 
MuLV  infected mice sacrificed at the same time was 5-15-fold greater. 
Establishment and  Characterization of Transformed Lines from  BALB- and Harvey-MSV- 
induced Colonies.  The ability of a  transforming virus to induce hematopoietic colony 
formation in tissue culture might reflect its direct transforming action or result from 
some indirect effect of virus infection such  as the production  of soluble factors that 
induce normal cellular proliferation. To differentiate between these two alternatives, 
it  is necessary to  determine  whether  such  colonies are capable of continued,  inde- 
pendent  proliferation.  Moreover,  if cell  lines  can  be  established,  it  is  possible  to 
characterize their phenotype with respect to malignant potential and stage of differ- 
entiation.  Thus,  efforts  were  undertaken  to  develop  clonal  cell lines  from  colonies 
induced by BALB- and Harvey-MSV. 
Individual  colonies  were  transferred  to  liquid  medium  in  microtiter  wells  and 
grown up to mass culture. The success rate for establishment of continuous cell lines 
could be improved with the initial use of conditioned medium or feeder layers. After 
an adaptation period of 1-6 wk, the transformed lines could be propagated independ- 
ently. Any cell line established in the presence of a  feeder layer was recloned in soft 
agar before its further characterization. 
The established lines grew to saturation densities of-2  ×  10 6 cells/ml and possessed 
generation  times  of  10-12  h.  Individual cell  lines  formed  colonies  in  soft  agar  at 
efficiencies ranging from  10-3 to  10 -1 (data not shown).  Some clonal lines have been 
in continuous culture for >8 mo. Each cell line tested was found to release transforming 
virus. Under the assay conditions used, many of the colonies selected were likely to 
have been infected with both sarcoma and helper virus. Nonetheless, we would have 
expected to obtain some nonproductively transformed lines from colonies that arose 
at  low multiplicities of infection.  Thus,  there  may  be some selective advantage  for JACALYN HOELZER PIERCE AND STUART A. AARONSON  879 
productively infected cells to develop into established lines. 
To analyze the malignant potential of the cell lines, we inoculated NFS/N weanling 
mice subcutaneously with 5 ×  106 cells from representative BALB- and Harvey-MSV 
transformed lines.  Each  cell line  tested was  oncogenic, forming very large  tumors 
within  1-2  wk.  Histopathologic analysis  revealed  the  tumors  to  be  comprised  of 
undifferentiated hematopoietic blast  cells.  In contrast, subcutaneous inoculation of 
weanlings with 5 ×  105 FFU of virus alone yielded either no detectable tumors or very 
small sarcomas, rather than hematopoietic tumors. To confirm the donor origin of 
the hematopoietic tumors, cells from BALB- and  Harvey-MSV-transformed hema- 
topoietic clones derived from male mice were injected subcutaneously into 5-wk-old 
female  mice.  The  tumors  that  formed  displayed  a  male  karyotype.  Moreover,  a 
metacentric chromosomal marker identified in one of the donor clones was shown to 
be present in the tumor cells derived from the recipient mouse. All of these results 
established  that  the  hematopoietic  lines  derived  from  BALB-  and  Harvey-MSV 
colonies were leukemogenic. 
Phenotype of BALB-  and Harvey-MSV Hematopoietic Transformants.  To  define  the 
phenotype of BALB- and Harvey-MSV-transformed hematopoietic cells, we analyzed 
clonal lines for markers that help to distinguish cells of various hematopoietic lineages. 
There was no evidence of hemoglobin synthesis as detected by benzidine staining (25), 
nor could the cells be induced to synthesize hemoglobin after exposure to DMSO or 
erythropoietin (Table III). The cells also lacked detectable nonspecific esterase or the 
ability to phagocytize latex beads, markers of cells within the myeloid series (Table 
III). 
To further define their stage of hematopoietic cell differentiation, we analyzed a 
number of individual clonal transformants for markers found associated with lym- 
phoid cells. ME has been shown to enhance normal lymphoid cell survival and growth 
in tissue culture (41, 42), as well as the growth capacity of certain lymphoblastic and 
myeloblastic tumor lines (43). ME has also been shown to be critical for hematopoietic 
cell colony formation by Abelson-MuLV and growth of Abelson-MuLV transformed 
lymphoid cells in culture (44, 38). The growth of BALB- and Harvey-MSV transform- 
ants was generally found to be dependent on the presence of ME (Table III). 
As shown in Table III, none of the lines induced by BALB-MSV and Harvey-MSV 
demonstrated detectable Thy-1 antigen as determined by complement-mediated lysis 
and fluorescence-activated cell sorting analysis  (T.  Storch and T. Chused, personal 
communication). The presence of Fc receptors on the cell surface is a characteristic of 
many  hematopoietic cell  types,  including  B  cells  of lymphoid  origin  (45).  When 
assayed for Fc receptors by the rosette assay (30), a low percentage of rosette formation 
was observed in some of the lines. The presence of low levels of Fc receptors on these 
lines was confirmed by fluorescence-activated cell sorting analysis (T. Storch and T. 
Chused, personal communication). However, other lines lacked detectable Fc receptors 
when analyzed by either technique. 
Pre-B lymphoid cells, which synthesize heavy/x chain in the absence of detectable 
light chain (46), appear to be the preferential target for Abelson-MuLV transforma- 
tion (47). When BALB- and Harvey-MSV transformants were analyzed for expression 
of mouse/~ chain,  none contained detectable levels as  determined by competition 
radioimmunoassay.  In  contrast,  5  out  of  12  Abelson-MuLV  in  vitro  transformed 
hematopoietic lines established in our laboratory produced readily detectable amounts 880  LYMPHOID  PROGENITOR  CELL TRANSFORMATION 
TABLE III 
Characterization of BALB- and Harvey-MSV Hematopoietic Cell Lines 
Marker 
Hematopoietic cell lines 
transformed by 
BALB-MSV  Harvey- 
MSV 
number positive~number tested 
Erythroid* 
Hemoglobin  0/6  0/6 
+  DMSO  O/6  O/6 
+ erythropoietin  0/6  0/6 
Myeloid~: 
Lysozyme  0/6  0/6 
Nonspecific esterase  0/6  0/6 
Nonspecific phagocytosis  0/6  0/6 
Lymphoids§ 
Mercaptoethanol dependence for growth  6/6  5/6 
Thy. l antigen  0/6  0/6 
Fc Receptors  4/6  3/6 
Cytoplasmic/1  0/6  0/6 
TdT  5/6  6/6 
* Hemoglobin synthesis was determined by benzidine staining as described in Materials and 
Methods. Cells were treated with 1.5% DMSO or 0.3 U/ml erythropoietin at the time of 
cell seeding. Staining was performed after 4 d of treatment. A Friend-MuLV erythroblast 
line, clone 745, was used as a positive control in this assay system. 
$ Lysozyme  levels were  assayed  by  the lysoplate  technique as  described in  experimental 
procedures. Amounts of lysozyme were determined per 106 cells added, using purified egg 
white lysozyme  as  a  standard.  The  sensitivity  of detection was  0.5  /tg.  Histochemical 
staining for nonspecific  esterase  was performed as described (26). Phagocytosis  of latex 
beads was determined as described in Materials and Methods. Cultures were incubated for 
1 h at an input of 500 beads/cell. Cells that internalized -> 10 beads were scored as positive. 
§ Exponentially growing clonal  lines  were  transferred at  a  l:20  split  ratio  into separate 
plates.  ME was omitted from the growth medium in one plate. Cultures were passaged 
every 3rd  d  and maintained for several weeks. Viability was monitored every  3rd  d  by 
trypan  blue  staining.  Cultures  were  discarded when  viability  decreased to  <5%.  The 
presence of Thy- 1 antigen was determined by complement-mediated  lysis as described in 
Materials and Methods. Complement or anti-Thy-1  antibodies alone did not exhibit any 
cytotoxicity  (<2% cell death). A Moloney-MuLV lymphoma cell line exhibited >99% lysis, 
whereas a Rauscher-MuLV pre-B lymphoma cell line demonstrated <2% cell death. The 
presence of Fc receptors was determined by the rossette assay as described in Materials and 
Methods. A cell line was considered  positive if 5-10% rosette formation was reproducibly 
detected. SRBC  alone or a  Moloney-MuLV T  lymphoma cell  line  did not  yield  any 
rosettes whereas  a  Rauscher-MuLV pre-B  lymphoma cell line demonstrated 65% rosette 
formation.  Cytoplasmic/~ chain synthesis was analyzed by radioimmunoassay as described 
(24). The sensitivity of/~ chain detection was -0.3 ng/mg of soluble cell protein. Cell lines 
were  considered  positive  for  TdT  if they  contained >0.1  U/10S/h  as  determined by 
enzymatic assay. 
of/z chain  (data not shown). The  lack of #  chain expression among  the BALB- and 
Harvey-MSV-transformed hematopoietic cell lines suggested that these cells might be 
at  an  earlier  stage  of  differentiation  than  pre-B  lymphoid  cells  transformed  by 
Abelson-MuLV. 
TdT  activity is a  characteristic of immature  lymphoid  cells of both T  and  B  cell 
lineage  (48-50).  As  shown  in  Table  IV,  BALB-  and  Harvey-MSV  transformants 
demonstrated TdT  activity at  levels ranging from 0.72  to 4.83  U/10 s  cells/h among JACALYN  HOELZER PIERCE AND STUART A. AARONSON 
TABLE IV 
TdT Activity in BALB- and Harvey-MSV-transformed 
Bone Marrow Cell Lines 
Cells  TdT activity* 
U/IO  8 cells/h 
Normal thymus~  2.19 
BALB-MSV 
Clone 1  1.31 
Clone 2  4.83 
Clone 3  2.38 
Harvey-MSV 
Clone 1  2.44 
Clone 2  0.72 
Clone 3  2.56 
Abelson-MuLV 
Clone 1  0.04 
Clone 2  0.02 
Friend-MuLV 
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Clone 745  <0.01 
* TdT values represent the average of duplicate samples. 1 U is equivalent to 
the incorporation of  one nmol of dGTP into acid insoluble material in 1 h at 
37°C. 
:]: Normal cells were obtained from 2-3-wk-old NFS/N weanling mice. 
several independent transformants analyzed. These levels were as high or higher than 
the  TdT  activity  detected  in  normal  thymus  cells  from  2-3-wk-old  NFS/N  mice 
(Table  IV)  (51).  In contrast,  Abelson-MuLV-transformed  cell  lines  of both #+  and 
/z- phenotypes contained very low level of TdT, ranging from 0.02 to 0.01 U/10  s cell/ 
h,  and  TdT  activity was  undetectable  in  a  Friend  erythroblast  cell  line,  clone  745 
(Table  IV).  To  examine  the  specificity  of the  enzymatic  assay,  cell  extracts  were 
incubated  with  antiserum  to  TdT  before  performing  the  enzymatic  assay.  This 
decreased incorporation of dGTP into acid-insoluble polymer by two- to threefold. A 
similar decrease was observed when purified TdT was tested under the same conditions 
(data not shown). 
Murine TdT is known to have a molecular weight of 60,000 (52). As an independent 
means of identifying and quantitating  the TdT activity in BALB- and Harvey-MSV 
transformants,  we performed radioimmunoprecipitation  analysis.  When ~S-methio- 
nine-labeled  cell extracts were exposed  to anti-TdT serum, a  60,000-mol wt protein 
was  precipitated  from  a  BALB-MSV  transformant  (Fig.  3).  Similar  results  were 
observed with extracts from normal thymus. In contrast, TdT was not detectable  in 
an  Abelson-MuLV  transformed  pre-B  cell  line  tested  under  the  same  conditions. 
These  findings  help  to  establish  the  identity  of our  BALB-  and  Harvey-MSV- 
hematopoietic transformants  as early cells within the lymphoid differentiation  path- 
way as well as distinguishing them from any previously reported targets of transform- 
ing retroviruses. 
Discussion 
BALB- and Harvey-MSV comprise a  family of retroviruses whose mouse- and rat- 
derived  onc  genes  are  closely related  and  whose  21,000-tool  wt  gene products  have 
been causally implicated in their respective transforming functions (11, 53, 54). In the 882  LYMPHOID  PROGENITOR  CELL  TRANSFORMATION 
Fla.  3.  Analysis of terminal deoxynucleotidyl transferase synthesis in normal and leukemic cells 
8fi  by immunoprecipitation. Cell extracts from  S-methionine labeled  (1) normal thymus; (2)  BALB- 
MSV transformed hematopoietic blast cells; and (3)  Abelson-MuLV transformed pre-B cells were 
treated with normal rabbit  serum (lane a)  or anti-terminal transferase (lane b)  as described in the 
Materials and Methods. Arrow at left identifies the position of TdT. Molecular weight markers are 
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present  report, we demonstrate that  these viruses transform a  novel hematopoietic 
target cell. Evidence that transformation was a  direct result of BALB- and Harvey- 
MSV infection was derived from the one-hit titration pattern for bone marrow colony 
formation, the absence of any detectable effect of helper virus alone, and the ability 
to  demonstrate  the  presence  of sarcoma  virus  in  cell  lines  established  from  such 
colonies. BALB- and Harvey-MSV induced colonies could be established in culture 
as  continuous  clonal  lines  with  high  proliferative capacity.  Their ability  to  form 
rapidly growing tumors of donor origin and with the same hematopoietic blast cell 
morphology confirmed their malignant potential. 
The hematopoietic blast cell transformants of BALB- and Harvey-MSV described 
in  this  report possessed  none of the markers  that  identify mature  cells within  the 
known hematopoietic lineages. The low level of Fc receptors detected on some clones 
does not place them in any specific lineage or stage of maturation  (45). Analysis of 
BALB- and Harvey-MSV transformants did not reveal any that contained detectable 
immunoglobulin  or  thymus  antigen.  In  contrast,  lymphoid  cells  transformed  by 
Abelson-MuLV in tissue culture appear to be at an early stage of B cell differentiation. 
The majority of such transformants synthesize immunoglobulin heavy/z chain in the 
absence of light chain (47).  In the avian system, reticuloendotheliosis virus (REV-T) 
transforms more immature lymphoid cells that generally lack immunoglobulin expres- 
sion  (55).  Both  Abelson-MuLV  and  REV-T  lymphoid  transformants  have  been 
reported to possess low or undetectable levels of TdT (56, 55). In contrast, BALB- and 
Harvey-MSV transformed hematopoietic blast cell lines contained very high levels of 
this  enzyme,  comparable  to  that  of normal  thymus.  The  different  phenotype  of 
BALB-  and  Harvey-MSV  transformants  compared  with  that  of Abelson-MuLV- 
transformed lymphoid cells induced under identical assay conditions demonstrates 
the  exquisite  specificity  that  retroviral  transforming  genes  can  have  for  cells  at 
different stages of differentiation, even within the same lineage. 
The growth-promoting actions of BALB- and Harvey-MSV for hematopoietic cells 
in culture is not limited to their transforming effects on early lymphoid cells reported 
here. These viruses also induce erythroid burst formation (16) and macrophage colony 
formation in infected bone marrow cell cultures (57). In neither case have permanent, 
malignant  cell lines  as  yet been established.  Thus,  whether the  growth-promoting 
activities of BALB- and Harvey-MSV on erythroid and macrophage cells is directly 
caused by virus transformation or the result of some indirect effect of the virus remains 
to be determined. 
Infection of newborn mice with Harvey-MSV has been shown to result in eryth- 
roleukemia  (15).  We  have  confirmed  the  striking  splenomegaly  associated  with 
Harvey-MSV infection and observed similar gross pathology in BALB-MSV inocu- 
lated animals.  We have also observed tumor involvement of the  thymic region in 
infected animals  that  has  not  been  previously reported.  When  we  analyzed bone 
marrow cells from such animals, we were able to detect hematopoietic colony-forming 
cells with the same blast cell phenotype observed after in vitro infection. In fact, the 
numbers of such colonies was only ~ 10-fold less  than  that observed with Abelson- 
MuLV. These findings indicate that the hematopoietic tumors induced by BALB- or 
Harvey-MSV may have a more complex etiology than has previously been supposed. 
The occurrence of TdT in prelymphoid cells has been well documented (48,  49). 
TdT is considered to be a specific marker for early lymphocytes because it is low or 884  LYMPHOID PROGENITOR CELL TRANSFORMATION 
absent  in mature lymphocytes. The existence of a  TdT  + Thy-1- bone marrow cell 
population has been indicated by findings that elimination of the Thy-1 + population 
by complement-mediated cytolysis does not significantly reduce TdT activity in the 
bone marrow (58).  That some of Thy-1- TdT  + bone marrow cells are committed to 
T  cell  differentiation  has  been  indicated  by  the  reduction  in  TdT  activity  after 
exposure to  thymopoietin followed by anti-Thy-1  complement-mediated lysis  (58). 
Our BALB- and Harvey-MSV transformants possessed a  stable TdT  + Thy-1- phe- 
notype. Thus, these cells appear to represent the malignant counterpart of a  normal 
lymphoid progenitor cell. It will be of interest to determine whether these cells have 
the capacity to differentiate along either T  or B cell developmental pathways after 
transformation by temperature-sensitive mutants or exposure to agents that promote 
differentiation in other systems (25,  58-60).  If so, these transformants should provide 
a useful approach for analysis of lymphoid cell ontogeny and the possible function of 
TdT in normal lymphocyte development. 
Summary 
BALB- and Harvey-murine sarcoma viruses  (MSV)  comprise a  family of retrovi- 
ruses whose mouse- and rat-derived onc genes are closely related. These viruses induce 
sarcomas and erythroleukemias in susceptible animals. An in vitro colony assay that 
detects transformation of lymphoid cells by Abelson-murine leukemia virus was used 
to demonstrate that BALB- and Harvey-MSV transform a  novel hematopoietic cell 
both  in  culture  and  in  vivo.  Bone  marrow  colony  formation  was  sarcoma  virus 
dependent, followed single-hit kinetics, and required the presence of mercaptoethanol 
in the agar medium. BALB- and Harvey-MSV-induced colonies could be established 
in culture as continuous cell lines that demonstrated unrestricted self-renewal capacity 
and  leukemogenicity  in  vivo.  The  cells  had  a  blast  cell  morphology  and  lacked 
detectable markers of mature cells within the myeloid or erythroid series. They also 
lacked  detectable  immunoglobulin  /~  chain  or  Thy-1  antigen,  markers  normally 
associated  with  committed  cells  of the  B  and  T  lymphoid  lineages,  respectively. 
However, the transformants contained very high levels of terminal deoxynucleotidyl 
transferase  (TdT),  an  enzyme  believed  to  be  specific  to  early  stages  within  the 
lymphoid  differentiation  pathway.  This  phenotype  distinguishes  these  BALB- and 
Harvey-MSV transformants from any previously reported  hematopoietic targets of 
transforming retroviruses, including the pre-B lymphoid cell transformed by Abelson- 
MuLV under identical assay conditions. These newly identified lymphoid progenitor 
cell  transformants  may  provide  an  important  means  of studying  early  stages  of 
lymphoid ontogeny and the possible role of TdT in lymphoid development. 
We thank Leslie Kalbfleisch  for excellent technical assistance, and T. Storch and T. Chused for 
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